Navigation Links
Harbinger Research Initiates Coverage on China Baicaotang Medicine, Ltd.
Date:5/11/2010

LIUZHOU CITY, China, May 11 /PRNewswire-Asia-FirstCall/ -- China Baicaotang Medicine Ltd. (OTC Bulletin Board: CNBI) ("CBT," or the "Company"), a provincial leader in pharmaceutical distribution and retailing in the Guangxi Province of China announced today that Harbinger Research, LLC, an independent equity research firm, will provide research coverage on the Company.

Mr. Tang Hui Tian, Chairman and CEO of CBT, stated that "Our Company is in the midst of growth and expansion in Guangxi province, and given our status as a U.S.-traded Company and plans to up-list to a national exchange in the near future, we feel Harbinger Research's coverage of CBT comes at an excellent time for CBT and its investors. We believe our company and industry will continue to demonstrate robust growth for years to come, as per-capita disposable income and government-driven pharmaceutical spending in China continue to grow."

Brian R. Connell, CFA, a Harbinger Research Senior Analyst, stated that, "We are excited to initiate coverage on China Baicaotang, which we believe is significantly undervalued on both a relative and absolute basis. We expect the pharmaceutical industry to remain strong in China for the foreseeable future, clearly benefiting all provincial industry leaders, including China Baicaotang."

To view Harbinger Research's coverage initiation on China Baicaotang Medicine, Ltd., rated by Brian R. Connell, CFA, please click on the following link:

SOURCE China Baicaotang Medicine Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Fate Therapeutics Appoints Tom Novak, Ph.D., as Vice President of Research and Drug Discovery
2. Orexigen(R) Therapeutics to Speak at Ninth Annual JMP Securities Research Conference
3. Silence Therapeutics Appoints New Vice President of Research
4. UCLA researchers use new microscope to see atoms for first time
5. TB Alliance and AstraZeneca Form Research Collaboration to Fight Tuberculosis
6. Knome Announces KnomeDISCOVERY Research Awards Program
7. The New York Stem Cell Foundation and The Johns Hopkins University School of Medicine to Collaborate on Stem Cell Research
8. Web-Based Management Suite Supports Complex Research Consortia
9. German MedSys Project Adopts Genedata Phylosopher for Research Informatics
10. New technique reinforces immune cells that seek and destroy cancer, says Stanford researcher
11. Materials research advances reliability of faster smart sensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... NEW YORK , June 1, 2015 /PRNewswire/ ... medical researcher  Eliseo Oreste Salinas , MD, MSc, ... and development. Dr. Salinas, who holds ... in pharmacology, brings a record of significant accomplishments ... in psychiatry.  Dr. Salinas has played ...
(Date:6/1/2015)... South Korea , June 1, 2015 ... Cross Biotherapeutics Inc. (GCBT) kicked off construction today on ... Montreal Technoparc,s Saint-Laurent Campus. The CA$315 million project represents ... Canada in the biopharmaceutical industry, ... immunoglobulin (IVIG) and albumin manufacturing plant in ...
(Date:6/1/2015)... 1, 2015 GenomeDx Biosciences today ... platform, successfully classified various subtypes of bladder ... certain biomarkers, including one type associated with ... genomic signature has potential as a tool ... in patients with muscle-invasive bladder cancers (MIBC). ...
(Date:6/1/2015)... Inc. (TSX-V: BRM) ("Biorem" or "the Company") today announced results for ... first quarter financial statements and MD&A have been filed on SEDAR ... 31,(in CDN$,000 except per share data) , 2015 , ... profit , 1,531 , 329 Ebitda* , ... , (531) Basic earnings (loss) per share ...
Breaking Biology Technology:Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Green Cross Biotherapeutics Kicks Off Construction in Montreal 2Green Cross Biotherapeutics Kicks Off Construction in Montreal 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4Biorem Reports Increased Revenues and Earnings for First Quarter 2Biorem Reports Increased Revenues and Earnings for First Quarter 3
... HILL, N.C., May 22 Pharmaceutical and biotech,companies increasingly ... (QA) functions. This benchmarking study will help R&D,Quality Assurance ... limited QA staff resources so that they have the ... services in regards to the FDA,s Risk-Bases method for ...
... BioElectronics President, CEO, and Chairman recaps recent investor ... ... May 22 Andrew Whelan,President and CEO of BioElectronics Corporation ... patch,with an embedded battery operated microchip that delivers pulsed,electromagnetic therapy, ...
... to Board, DUBLIN, May 22 Amarin Corporation ... closed the $30 million first,tranche of its previously announced ... tranche, after deducting the placement agents, fees,and estimated offering ... with the financing, Amarin has appointed to its Board,representatives ...
Cached Biology Technology:Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 3BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 4BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 5BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 6BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 7BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 8Amarin Announces Completion of the First Tranche of $60 Million Private Placement 2Amarin Announces Completion of the First Tranche of $60 Million Private Placement 3Amarin Announces Completion of the First Tranche of $60 Million Private Placement 4Amarin Announces Completion of the First Tranche of $60 Million Private Placement 5
(Date:5/19/2015)... 19, 2015 Research ... addition of the  "Genetic Testing Market Outlook ... http://photos.prnewswire.com/prnh/20130307/600769) , ,A recent report, Genetic Testing ... of the current and future genetic testing ... their working principles and types are covered ...
(Date:5/11/2015)... 2015  Through a well-rounded UAS delegation representing private industry, ... strong showing at AUVSI,s Unmanned 2015 conference last week in ... Ohio,s UAS industry met with over 200 hundred ... along the UAS ecosystem. "Our message is ... for Aerospace Rich Knoll . "If you want to ...
(Date:5/6/2015)... AVIV, Israel , May 6, 2015 ... world,s most established helmet producer, announced today that they ... Smart Helmet, the world,s first bio-sensing cycling helmet and ... be released in two new colors in order to ... for the product. In addition, LifeBEAM and Lazer announced ...
Breaking Biology News(10 mins):Global Genetic Testing Market Outlook 2018 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... Understanding whether inbreeding accounts for early mortality is a ... Bekaa, Lebanon, in which the marriage rate among first ... new study appearing in the October issue of Current ... mortality is not closely related parents though this ...
... areas seem to have a marked advantage over their rural ... much larger range of conditions. In fact, new research ... many urban bird species means they don,t just survive but ... very challenging environment. "The urban habitat is usually more ...
... -- Topics include: discovery of exceptionally preserved soft-bodied ... arctic lake containing sediments 200,000 years old; effects of ... northern Guatemala; a new catalog of episodic tremor and ... model of Sierra Nevada volcanism and uplift. The GSA ...
Cached Biology News:'Kissing cousins' 2City birds better than rural species in coping with human disruption 2October Geology and GSA Today media highlights 2October Geology and GSA Today media highlights 3October Geology and GSA Today media highlights 4October Geology and GSA Today media highlights 5October Geology and GSA Today media highlights 6October Geology and GSA Today media highlights 7October Geology and GSA Today media highlights 8October Geology and GSA Today media highlights 9October Geology and GSA Today media highlights 10October Geology and GSA Today media highlights 11
... calcium binding proteins such as calmodulin and troponin ... and beta chain whereas S100B is composed of ... expressed in the antigen presenting cells such as ... cells in the paracortex of lymph nodes. ...
LEAF™ Purified anti-human/mouse/rat ICOS...
Peptide-affinity Purified Polyclonal Antibody to MTR...
Purified anti-eIF-4E...
Biology Products: